Latest Post

New TB drug approval a milestone, all agree — with caveats, some add

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]

More »

Recent Posts

Amid other challenges, Burundi begins front-line, health worker Ebola vaccinations at border

DRC neighbor boosts preparedness for spread of virus while grappling with increasing malaria cases, continued cholera outbreak Burundi’s health ministry Tuesday launched a campaign to vaccinate  health workers and others on the front line of a Democratic Republic of Congo border crossing Tuesday, the most recent in a series of steps preparing for the eventuality […]

More »

Improved Ebola survival rates with study treatments raise hopes, challenges

Announcing favorable results from two of four Ebola treatment candidates being used in a randomized clinical trial among patients in the ongoing Democratic Republic of Congo outbreak, officials from the National Institute of Allergy and Infectious Diseases, the World Health Organization, and a veteran Democratic Republic of Congo researcher today heralded preliminary data as yielding […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]

Tuberculosis

New TB drug approval a milestone, all agree — with caveats, some add

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]

Research & Development

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]

Policy

With data on largest AFM outbreak yet, CDC urges readiness to recognize, report cases

With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]